Thomas Garner insider trades

Open-market stock purchases and sales by Thomas Garner, EVP, Chief Commercial Officer at Acadia Pharmaceuticals Inc, from SEC Form 4 filings since Oct 9, 2023.

Recent trades

DateStockTradeValue
Mar 6, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
Mar 6, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—

Companies traded

  • ACAD Acadia Pharmaceuticals Inc: other filings, last Mar 6, 2026
  • LXRX Lexicon Pharmaceuticals, Inc: other filings, last Feb 8, 2024

Get free alerts when Thomas Garner files a new trade →